Sotevtamab, a novel bispecific antibody , is sparking considerable excitement within the oncology community, particularly regarding its promise for managing blood cancers. This therapy works by https://agnesfylm487308.mpeblog.com/74658441/sotevtamab-the-new-hope-in-hematologic-malignancies